Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides.

Area of Science:

• Medicinal Chemistry
• Microbiology
• Biotechnology

Background:

• Antimicrobial peptides (AMPs) offer broad-spectrum efficacy and novel mechanisms to combat antibiotic resistance.
• Clinical translation of AMPs is hindered by poor stability and host cell toxicity.
• New strategies like size reduction and lipid conjugation are needed to improve AMPs' therapeutic potential.

Purpose of the Study:

• To design and synthesize a library of ultra-short lipopeptides with enhanced stability, cell penetration, and safety.
• To evaluate the in vitro antibacterial activity of these novel lipopeptides against Gram-negative and Gram-positive bacteria.
• To identify lead compounds with optimal lipophilicity, stability, and a favorable safety profile for further development.

Main Methods:

• De novo design of lipopeptides utilizing a rigid l-Arg-l-Pro-l-Arg core.
• Chemical synthesis and systematic modulation of lipid positioning and linker orientation.
• In vitro evaluation of antibacterial activity (MIC values), human serum stability, cytotoxicity assays (renal, hepatic, red blood cells), and S. aureus biofilm inhibition.

Main Results:

• Identified promising lipopeptide candidates with minimum inhibitory concentrations (MICs) in the low-μM range against both Gram-negative and Gram-positive bacteria.
• Compound 15 demonstrated optimal lipophilicity, excellent human serum stability, and a favorable safety profile with low to moderate toxicity.
• Compound 15 effectively reduced S. aureus biofilm formation and showed potent activity against clinical isolates, acting via bacterial membrane perturbation.

Conclusions:

• Ultra-short lipopeptides based on a rigid core represent a novel chemotype with significant therapeutic potential.
• These lipopeptides overcome limitations of traditional AMPs, offering improved stability and safety.
• Compound 15 is a promising lead for developing new strategies against challenging bacterial infections, including those caused by S. aureus.